Victor Liu
Boston, MANPI 1790279412
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.1%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 53.3% of the total. Reporting peaked in 2024 at $8,544 and has fallen 72.9% since, to $2,319 in 2025.
Across 161 payments — averaging $123.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Boston Scientific$4K
- Medtronic$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$504
- Philips North America LLC$487
- Amgen$219
- plus $1K from 12 others
Across 2 payments — averaging $108.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$217
What the payments were for
- Grants$4,12621%
- Travel & lodging$6,63533%
- Food & beverage$8,97745%
- Education$1541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 76 | $10,595 |
| Boston Scientific | 26 | $4,117 |
| Medtronic | 25 | $2,798 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $504 |
| Philips North America LLC | 2 | $487 |
| Amgen | 6 | $219 |
| Shockwave Medical, Inc | 1 | $181 |
| Lantheus Medical Imaging, Inc. | 3 | $164 |
| Heartflow, Inc. | 2 | $154 |
| Biotronik Inc. | 1 | $143 |
| Angiodynamics, Inc. | 1 | $125 |
| Pfizer | 5 | $118 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $101 |
| Sanofi-aventis U.S. LLC | 1 | $91 |
| Edwards Lifesciences | 1 | $35 |
| Lexicon Pharmaceuticals, Inc. | 1 | $24 |
| Novartis | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIENCE V$3,000
- OPTIS$2,164
- CARDIOMEMS$1,759
- TurboHawk$1,133
- COREVALVE EVOLUT R$704
- (9520) IGT Devices Undivided$487
- ENSITE$437
- Perclose ProStyle$385
- iLab Ultrasound Imaging System$292
- Diamondback Peripheral$287
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$181
- ROTAPRO$174
- IN.PACT Admiral$168
- Rivacor 7 DR-T$143
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$136
- FFRct$135
- Repatha$130
- AlphaVac$125
- COMET$125
- SYNERGY$124
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 24 | $270 |
| Carvedilol | 18 | $171 |
| Atorvastatin Calcium | 11 | $107 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.